CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 5, 2018--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that members of the company's management team will present at the following upcoming investor conferences:

Goldman Sachs Annual Healthcare Conference on Tuesday, June 12, 2018 at 1:20 p.m. P.T. in Rancho Palos Verdes, California. William Blair Growth Stock Conference on Thursday, June 14, 2018 at 8:40 a.m. C.T. in Chicago.

A live, listen-only webcast of the presentation may be accessed by visiting the investors section of the company’s website at investors.foundationmedicine.com. A replay of the webcast will be available shortly after the conclusion of each presentation and will be archived on the company's website for 90 days.

About Foundation Medicine Foundation Medicine (NASDAQ:FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine ® is a registered trademark of Foundation Medicine, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180605005186/en/

CONTACT: Foundation Medicine, Inc.

Media Contact:

Lee-Ann Murphy, 617-245-3077

pr@foundationmedicine.com

or

Investor Contact:

Kimberly Brown, 617-418-2215

ir@foundationmedicine.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS GENETICS ONCOLOGY PHARMACEUTICAL

SOURCE: Foundation Medicine, Inc.

Copyright Business Wire 2018.

PUB: 06/05/2018 07:00 AM/DISC: 06/05/2018 07:01 AM

http://www.businesswire.com/news/home/20180605005186/en